View Article

Abstract

Background: Chest X-ray (CXR) remains the most widely used imaging modality for evaluating pulmonary diseases. Interpretation of lung opacities on CXRs is traditionally qualitative and subject to inter-observer variability. Artificial intelligence (AI) offers an opportunity for objective and reproducible quantification of lung opacities. Objectives: To quantitatively assess lung opacity extent on routine chest X-rays using AI-based analysis, compare AI scores with radiologist grading, and evaluate the relationship between lung opacity severity and clinical outcomes. Methods: A prospective cross-sectional observational study was conducted on 80 patients with radiographically evident lung opacities at a tertiary care hospital. AI-based image processing software quantified lung opacity extent (%) and generated opacity scores. These were compared with radiologist-assigned opacity grades. Statistical analysis included descriptive statistics, ANOVA, chi-square test, Pearson correlation, and ROC curve analysis. Results: The mean lung opacity extent was 46.59 ? 25.74%. No statistically significant difference in opacity extent was observed across different pulmonary diagnoses (ANOVA, p = 0.489). AI opacity scores showed no significant association with radiologist grading (?? = 160.0, p = 0.441). Lung opacity extent did not correlate with hospital stay duration (r = 0.001, p = 0.991). ROC analysis demonstrated poor predictive performance of AI opacity score for severity classification (AUC = 0.584). Conclusion: AI-based quantitative lung opacity analysis provides objective measurements but showed limited agreement with radiologist interpretation and poor predictive accuracy for disease severity. Further refinement of AI models and integration with clinical parameters are required to enhance clinical utility.

Keywords

Chest X-ray, Lung opacity, Artificial intelligence, Quantitative imaging, Computer-aided diagnosis

Introduction

Pulmonary diseases such as pneumonia, tuberculosis, pulmonary edema, interstitial lung disease, and lung cancer remain major contributors to global morbidity and mortality. Chest X-ray (CXR) imaging continues to be the most frequently employed diagnostic modality for initial evaluation of suspected lung pathology due to its wide availability, low cost, rapid acquisition, and relatively low radiation dose [1]. Detection and interpretation of lung opacities on CXRs play a central role in clinical decision-making, disease staging, and treatment monitoring. Despite its clinical importance, conventional interpretation of lung opacities on chest radiographs is largely qualitative and dependent on the experience of the radiologist. This subjectivity leads to considerable inter-observer variability, particularly in cases with subtle, diffuse, or overlapping radiographic findings [2]. Variations in image quality, patient positioning, and anatomical superimposition further complicate accurate assessment, potentially resulting in delayed diagnosis or inconsistent severity grading [3]. Recent advances in computer-aided diagnosis (CAD) and artificial intelligence (AI) have introduced quantitative approaches to chest radiograph analysis. These methods enable objective measurement of lung opacity extent, density, and spatial distribution, thereby reducing observer-dependent bias and improving reproducibility [4]. Quantitative lung opacity analysis has shown particular value in disease severity assessment, longitudinal monitoring, and evaluation of treatment response, especially in settings where advanced imaging modalities such as computed tomography (CT) are not readily accessible [5]. Chest X-ray remains indispensable in emergency departments, outpatient clinics, and intensive care units, where rapid decision-making is critical [6]. However, the limitations of purely visual assessment have prompted growing interest in automated image analysis techniques. Deep learning-based models have demonstrated promising performance in detecting and quantifying lung opacities associated with pneumonia, tuberculosis, interstitial lung disease, and viral infections, including COVID-19 [7,8]. During the COVID-19 pandemic, AI-assisted CXR analysis proved valuable for severity stratification, triage, and outcome prediction, highlighting the clinical relevance of quantitative imaging tools [9]. Lung opacities represent regions of increased pulmonary density on chest radiographs and may arise from infectious, inflammatory, neoplastic, or vascular processes. Radiographically, these opacities manifest in diverse patterns such as alveolar consolidation, interstitial thickening, nodular lesions, ground-glass opacities, and reticular or honeycomb patterns, each associated with specific disease processes [10]. Accurate characterization of these patterns is essential for differential diagnosis, yet qualitative interpretation alone often fails to capture subtle differences in extent and severity. Quantitative analysis offers several advantages over traditional qualitative assessment. Automated segmentation and pixel-based density analysis allow precise estimation of the percentage of lung involvement, facilitating standardized severity scoring and enabling meaningful comparisons across patients and time points [11]. Moreover, AI-driven systems can process large volumes of imaging data efficiently, supporting high-throughput clinical workflows and reducing radiologist workload [12]. Despite these advancements, challenges remain, including variability in image acquisition protocols, limited availability of annotated datasets, and concerns regarding generalizability across populations. Nonetheless, ongoing developments in deep learning architectures, federated learning, and multi-institutional training frameworks continue to enhance the robustness of AI-based imaging tools [13]. Given the persistent reliance on chest radiography for pulmonary disease evaluation, particularly in resource-limited settings, there is a pressing need for accurate, objective, and reproducible methods to quantify lung opacities on routine CXRs. Integrating AI-based quantitative analysis into standard radiological practice has the potential to improve diagnostic consistency, support clinical decision-making, and enhance patient outcomes. The present study aims to evaluate AI-based quantitative lung opacity assessment on routine chest X-ray radiographs and examine its diagnostic utility in comparison with conventional radiologist interpretation.

MATERIALS AND METHODS

Study Design and Setting

This study was designed as a prospective cross-sectional observational study conducted in the Department of Radiology at SCPM Hospital, Gonda, Uttar Pradesh, India. The study was carried out over a defined study period after obtaining institutional ethical clearance and written informed consent from all participants.

Study Population

The study population comprised adult patients referred for routine chest X-ray examination with radiographically detectable lung opacities. A total of 80 patients were included using a purposive sampling technique to ensure representation of common pulmonary pathologies.

Inclusion Criteria

  • Patients aged 18 years and above
  • Presence of lung opacities on routine chest X-ray
  • Diagnosed or clinically suspected cases of pneumonia, tuberculosis, pulmonary edema, interstitial lung disease, or lung malignancy
  • Patients who provided written informed consent

Exclusion Criteria

  • Patients with normal chest X-ray findings
  • Chest X-rays with severe motion artifacts or poor image quality unsuitable for analysis
  • Patients with prior thoracic surgery or congenital lung abnormalities
  • Patients unwilling to participate

Image Acquisition

All chest X-ray images were acquired using a digital radiography system following standard departmental protocols. Posteroanterior (PA) chest radiographs were obtained whenever feasible, with patients positioned erect and instructed to hold breath at full inspiration. Exposure parameters were adjusted according to patient body habitus to ensure optimal image quality. Image quality was later categorized as good, average, or poor based on radiographic clarity and diagnostic adequacy.

AI-Based Lung Opacity Quantification

Digital chest X-ray images were analyzed using computer-aided diagnosis (CAD) software integrated with artificial intelligence algorithms. The AI system performed automated lung field segmentation, separating normal lung parenchyma from pathological regions. Lung opacity extent was calculated as the percentage of lung area involved, based on pixel density and segmentation outputs. An AI opacity score ranging from 0 to 1 was generated for each image, reflecting the severity of lung opacity. Based on predefined thresholds, AI scores were categorized into low, moderate, and high severity groups for comparative analysis.

Radiologist Assessment

All chest X-ray images were independently reviewed by qualified radiologists who were blinded to the AI results. Lung opacities were graded visually as low, medium, or high severity based on extent, density, and distribution of opacities. These assessments served as the reference standard for comparison with AI-derived scores.

Clinical Data Collection

Demographic and clinical data were collected using a structured proforma and included:

  • Age and gender
  • Smoking status
  • Clinical diagnosis
  • Duration of hospital stay

All patient data were anonymized prior to analysis.

Sample Size Calculation

The sample size was calculated using a standard formula for cross-sectional studies, assuming a 95% confidence level and a margin of error of 10%. Based on feasibility and study duration, a final sample size of 80 patients was included.

Statistical Analysis

Statistical analysis was performed using SPSS software.

  • Descriptive statistics (mean, standard deviation, frequency, and percentage) were used to summarize demographic variables, lung opacity extent, AI scores, and hospital stay duration.
  • One-way Analysis of Variance (ANOVA) was applied to assess differences in lung opacity extent across different pulmonary diagnoses.
  • Chi-square test was used to evaluate the association between AI-based opacity categories and radiologist-assigned opacity grades.
  • Pearson correlation analysis was conducted to examine the relationship between lung opacity extent and duration of hospital stay.
  • Receiver Operating Characteristic (ROC) curve analysis was performed to assess the diagnostic performance of the AI opacity score in classifying lung opacity severity.

A p-value < 0.05 was considered statistically significant for all analyses.

RESULTS

A total of 80 patients with radiographically detectable lung opacities on routine chest X-ray were included in the analysis. The results are presented under demographic characteristics, radiographic findings, AI-based opacity analysis, and statistical associations.

Table 1. Gender Distribution of Study Participants (N = 80)

Gender

Frequency

Percentage (%)

Male

38

47.5

Female

42

52.5

Total

80

100

Interpretation:
The study population showed a nearly equal gender distribution, with a slight predominance of females (52.5%). This balanced distribution reduces gender-related sampling bias and allows reliable comparison of imaging findings.

Table 2. Smoking Status Distribution

Smoking Status

Frequency

Percentage (%)

Smoker

42

52.5

Non-smoker

38

47.5

Total

80

100

Interpretation:
More than half of the participants were smokers (52.5%), which is clinically relevant given the known association between smoking and chronic lung pathologies, malignancy, and interstitial lung disease.

Table 3. Frequency Distribution of Diagnoses

Diagnosis

Frequency

Percentage (%)

Tuberculosis

20

25.0

Pneumonia

18

22.5

Interstitial Lung Disease

14

17.5

Lung Cancer

14

17.5

Pulmonary Edema

14

17.5

Total

80

100

Interpretation:
Tuberculosis was the most common diagnosis (25%), followed by pneumonia (22.5%). This distribution reflects the high burden of infectious lung diseases in routine clinical practice, especially in resource-limited settings.

Table 4. Distribution of Lung Opacity Severity (AI-Based)

Opacity Severity

Frequency

Percentage (%)

Mild

28

35.0

Moderate

22

27.5

Severe

30

37.5

Total

80

100

Interpretation:
Severe lung opacities were observed in 37.5% of patients, indicating that a substantial proportion presented with advanced radiographic involvement at the time of imaging.

Table 5. Radiologist Opacity Grading

Opacity Grade

Frequency

Percentage (%)

Low

30

37.5

Medium

25

31.3

High

25

31.3

Total

80

100

Interpretation:
Radiologist grading showed the highest proportion of cases classified as low severity (37.5%). Distribution across grades highlights subjective variation in visual assessment.

Table 6. Image Quality Assessment

Image Quality

Frequency

Percentage (%)

Good

30

37.5

Average

23

28.7

Poor

27

33.8

Total

80

100

Interpretation:
Only 37.5% of CXRs were graded as good quality, emphasizing the importance of AI-based analysis that can function reliably even with suboptimal imaging conditions.

Table 7. Descriptive Statistics

Variable

Mean ± SD

Minimum

Maximum

Age (years)

46.34 ± 17.74

20

79

Lung Opacity Extent (%)

Reference

  1. Urban T, Gassert FT, Frank M, Willer K, Noichl W, Buchberger P, et al. Qualitative and Quantitative Assessment of Emphysema Using Dark-Field Chest Radiography. Radiology. 2022;303(1):119–27.
  2. Gassert FT, Urban T, Frank M, Willer K, Noichl W, Buchberger P, et al. X-ray Dark-Field Chest Imaging: Qualitative and Quantitative Results in Healthy Humans. Radiology. 2021;301(2):389–95.
  3. Arias-Garzón D, Alzate-Grisales JA, Orozco-Arias S, Arteaga-Arteaga HB, Bravo-Ortiz MA, Mora-Rubio A, et al. COVID-19 detection in X-ray images using convolutional neural networks. Machine Learning with Applications. 2021; 6:100138.
  4. Orsi MA, Oliva G, Toluian T, Pittino CV, Panzeri M, Cellina M. Feasibility, Reproducibility, and Clinical Validity of a Quantitative Chest X-ray Assessment for COVID-19. Am J Trop Med Hyg. 2020;103(2):822–7.
  5. Wang Y, Li W, Luo J, Aguilera T. Deep learning in chest radiography: Detection, classification, and beyond. Radiology. 2020;296(3): E86-E96.
  6. Cozzi D, Albanesi M, Cavigli E, Moroni C, Bindi A, Luvarà S, et al. Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome. Radiol Med. 2020;125(8):730–7.
  7. Toussie D, Voutsinas N, Finkelstein M, Cedillo MA, Manna S, Maron SZ, et al. Clinical and chest radiography features determine patient outcomes in young and middle-aged adults with COVID-19. Radiology. 2020;297(1): E197–206.
  8. Yasin R, Gouda W. Chest X-ray findings monitoring COVID-19 disease course and severity. Egypt J Radiol Nucl Med. 2020;51(1).
  9. Rousan LA, Elobeid E, Karrar M, Khader Y. Chest x-ray findings and temporal lung changes in patients with COVID-19 pneumonia. BMC Pulm Med. 2020;20(1):1–9.
  10. Arias-Londoño JD, Moure-Prado Á, Godino-Llorente JI. Automatic Identification of Lung Opacities Due to COVID-19 from Chest X-ray Images—Focusing Attention on the Lungs. Diagnostics. 2023;13(8).
  11. Smith AC, Thomas E, Al-Githmi I, Chandrasekhar R. Quantitative analysis of pulmonary opacities on chest radiographs. J Med Imaging Radiat Oncol. 2019;63(5):650-657.
  12. Nagar, M., Saxena, A.K., Khangarot, S., Bansiwal, B., Anees, K.V., & Phulwari, J. (2017). A study of respiratory distress in patients with bilateral lung opacities admitted in a tertiary care hospital. International Journal of Advances in Medicine, 4, 1005-1009.
  13. Sichletidis, L.T., Moustakas, I., Chloros, D., Vamvalis, C., Palladas, P., & Sidiropoulou, M.S. (2004). Scattered micronodular high density lung opacities due to mercury embolism. European Radiology, 14, 2146-2147.
  14. Singh, A., James, R., Kaur, R., & Singh, J. (2012). An unusual cause of photographic negative of pulmonary edema: Sarcoidosis. Lung India: Official Organ of Indian Chest Society, 29, 390 - 391.
  15. Arias-Londoño, J.D., Moure-Prado, Á., & Godino-Llorente, J.I. (2023). Automatic Identification of Lung Opacities Due to COVID-19 from Chest X-ray Images—Focussing Attention on the Lungs. Diagnostics, 13.

Photo
Pankaj Kumar
Corresponding author

Department of Paramedical Science, SCPM College of Nursing & Paramedical Sciences, Gonda

Photo
Sandhya Verma
Co-author

Department of Paramedical Science, SCPM College of Nursing & Paramedical Sciences, Gonda

Photo
Shubhanshi Rani
Co-author

Department of Paramedical Science, SCPM College of Nursing & Paramedical Sciences, Gonda

Photo
Jyoti Yadav
Co-author

Department of Paramedical Science, SCPM College of Nursing & Paramedical Sciences, Gonda

Photo
Shivam Sing
Co-author

Department of Paramedical Science, SCPM College of Nursing & Paramedical Sciences, Gonda

Pankaj Kumar*, Sandhya Verma, Shubhanshi Rani, Jyoti Yadav, Shivam Sing, Quantitative Analysis of Lung Opacities on Routine Chest X-Ray Radiograph, Int. J. Sci. R. Tech., 2026, 3 (1), 144-151. https://doi.org/10.5281/zenodo.18220096

More related articles
Acorus Calamus: An Ancient Remedy with Modern Medi...
Chandraprabha Dewangan , Rahul Kashyap, Shivaji Patel, GyaneshKum...
Exploring the Antidiabetic Potential of Atovaquone: Insights from Streptozotocin...
Rushikesh Kale , Deepak Ambhore , Dr. G. V. Bihani , Dr. K. R. Biyani , ...
A Review on Gastro Retentive Drug Delivery System (GRDDS)...
Mayur Pawar, Rushikesh Patkal, Pratiksha Bhalekar, Omkar Karad, ...
Related Articles
Ethnomedicinal Plants Used in Gujarat For the Treatment of Various Diseases...
Hitesh Kumarkhaniya, Jagruti Nandaniya, Bharat Maitreya, ...
Diuretics — A Review of the Current Knowledge...
Akash Jadhav, Varad Dhobale, Aishwarya Pise, ...
Cyber Security Awareness Among Genz...
J. Anurushmitha, D. Nikhitha, J. P. Pramod, ...
Quality by Design in HPTLC: A Review of Method Development Approaches...
L. P. Jain, M. S. Charde, S. J. Momin, S. V. Potdar, N. D. Kulkarni, ...